VXRT News and Press, Vaxart Inc. From 07/27/23

Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the second quarter ended June 30, 2023 after the market close on Thursd...

2023-07-06 10:33:23 ET Vaxart ( NASDAQ: VXRT ) announced Thursday that its Phase 2 clinical trial for an oral bivalent norovirus vaccine candidate met all primary endpoints, leading to strong immune responses across all dose levels. There are currently no approved vaccines for n...

Met all primary endpoints : Vaccine was well-tolerated with robust immunogenicity Continue to expect topline data from Phase 2 GI.1 challenge study in Q3 2023 SOUTH SAN FRANCISCO, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced positive to...

SOUTH SAN FRANCISCO, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today held its Annual Meeting of Shareholders in a virtual-only format. Preliminary results from the Annual Meeting indicate that all four proposals were approved by Vaxart shareholders. Sharehol...

SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today encourages its stockholders of record on April 28, 2023, to vote on its proxy if they have not yet done so. The Company urges a y es vote on all Proxy proposals. Leading proxy advisors ISS an...

2023-06-07 10:01:47 ET Gainers: Avrobio ( AVRO ) +10% . Cardiff Oncology ( CRDF ) +8% . IceCure Medical ( ICCM ) +7% . Humacyte ( HUMA ) +6% . TScan Therapeutics ( TCRX ) +4% . Losers: Vaxart ( VXRT ) -27% . Carism...

2023-06-07 09:18:32 ET Vaxart ( NASDAQ: VXRT ) said Wednesday it launched an underwritten public stock offering , sending its shares 25.3% lower before the bell. The underwriter will be given a 30-day option to buy up to an additional 15% of shares sold in the offering...

SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the pricing of its underwritten public offering of 16,000,000 shares of its common stock, for gross proceeds of approximately $15,000,000, before deducting the underwriting discounts and com...

2023-06-07 08:27:22 ET United Natural Foods ( UNFI ) -24% after Q3 earning release , Mondee Holdings ( MOND ) -24% announces pricing of secondary offering of common stock by selling stockholders. Vaxart ( VXRT ) -23% announces proposed public offe...

SOUTH SAN FRANCISCO, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has commenced an underwritten public offering of its common stock. In addition, Vaxart expects to grant to the underwriter a 30-day option to purchase up to an additional 15% of shar...